| http://dbpedia.org/ontology/abstract
|
LY-344,545 is a research drug developed by … LY-344,545 is a research drug developed by the pharmaceutical company Eli Lilly, which acts as an antagonist for the metabotropic glutamate receptor subtype mGluR5. It is an epimer of another metabotropic glutamate receptor antagonist, the mGluR2/3-selective LY-341,495.gonist, the mGluR2/3-selective LY-341,495.
|
| http://dbpedia.org/ontology/casNumber
|
201851-20-9
|
| http://dbpedia.org/ontology/fdaUniiCode
|
9ZSQ1C4209
|
| http://dbpedia.org/ontology/pubchem
|
10618042
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/LY-344545_Structure.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
22218242
|
| http://dbpedia.org/ontology/wikiPageLength
|
3240
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1085711100
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Eli_Lilly_and_Company_brands +
, http://dbpedia.org/resource/Metabotropic_glutamate_receptor_5 +
, http://dbpedia.org/resource/Eli_Lilly_and_Company +
, http://dbpedia.org/resource/Category:MGlu5_receptor_antagonists +
, http://dbpedia.org/resource/Category:Xanthenes +
, http://dbpedia.org/resource/LY-341%2C495 +
, http://dbpedia.org/resource/Metabotropic_glutamate_receptor +
, http://dbpedia.org/resource/Receptor_antagonist +
, http://dbpedia.org/resource/Epimer +
|
| http://dbpedia.org/property/c
|
20
|
| http://dbpedia.org/property/casNumber
|
201851
|
| http://dbpedia.org/property/chemspiderid
|
8793407
|
| http://dbpedia.org/property/h
|
19
|
| http://dbpedia.org/property/iupacName
|
-α-Amino-α-[-2-carboxycyclopropyl]-9H-xanthene-9-propanoic acid
|
| http://dbpedia.org/property/n
|
1
|
| http://dbpedia.org/property/o
|
5
|
| http://dbpedia.org/property/pubchem
|
10618042
|
| http://dbpedia.org/property/smiles
|
c1ccc2cCC[C@]N
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
VLZBRVJVCCNPRJ-RCDCFZSISA-N
|
| http://dbpedia.org/property/unii
|
9
|
| http://dbpedia.org/property/verifiedrevid
|
424883636
|
| http://dbpedia.org/property/watchedfields
|
changed
|
| http://dbpedia.org/property/width
|
160
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Drugbankcite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Nervous-system-drug-stub +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Metabotropic_glutamate_receptor_modulators +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:MGlu5_receptor_antagonists +
, http://dbpedia.org/resource/Category:Eli_Lilly_and_Company_brands +
, http://dbpedia.org/resource/Category:Xanthenes +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/LY-344545?oldid=1085711100&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/LY-344545_Structure.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/LY-344545 +
|
| owl:sameAs |
http://sh.dbpedia.org/resource/LY-344%2C545 +
, https://global.dbpedia.org/id/4pn6u +
, http://sr.dbpedia.org/resource/LY-344%2C545 +
, http://dbpedia.org/resource/LY-344545 +
, http://www.wikidata.org/entity/Q6460427 +
|
| rdf:type |
http://dbpedia.org/ontology/Drug +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/ChemicalSubstance +
|
| rdfs:comment |
LY-344,545 is a research drug developed by … LY-344,545 is a research drug developed by the pharmaceutical company Eli Lilly, which acts as an antagonist for the metabotropic glutamate receptor subtype mGluR5. It is an epimer of another metabotropic glutamate receptor antagonist, the mGluR2/3-selective LY-341,495.gonist, the mGluR2/3-selective LY-341,495.
|
| rdfs:label |
LY-344545
|
